Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer

Trudy C. Wu, Annalise Stube, Carol Felix, Denise K. Oseguera, Tahmineh Romero, Jonathan W. Goldman, Edward B. Garon, Jay M. Lee, John A. Glaspy, Aaron Lisberg, Chad G. Rusthoven, D. Ross Camidge, Shankar Siva, Benjamin Solomon, Alan Lee, Stephen Tenn, Narek Shaverdian, Michael L. Steinberg, Ann C. Raldow, Percy Lee